Search Login Register
Trimethoprim-Sulfamethoxazole Combination
(Co-Trimoxazole)
Summary
Description:
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
Also Known As:
Co-Trimoxazole; Lescot; Bactrim; Centran; Septra Show All >>
Networked: 3778
relevant articles (426 outcomes,
438 trials/studies)
for this Drug
Key Diseases for which Trimethoprim-Sulfamethoxazole Combination is
Relevant
-
Infection
:
93 outcomes 76 studies in 770 results
-
Urinary Tract Infections (Urinary Tract Infection)
:
53 outcomes 69 studies in 383 results
-
Pneumonia (Pneumonitis)
:
29 outcomes 23 studies in 223 results
-
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
:
24 outcomes 29 studies in 291 results
-
Malaria
:
20 outcomes 13 studies in 80 results
Show All >>
Drugs Related to Trimethoprim-Sulfamethoxazole Combination
-
Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
-
Trimethoprim (Proloprim)
-
Thymidine Monophosphate (TMP)
-
Sulfamethoxazole
-
Ampicillin (Omnipen)
-
Rifampin (Rifampicin)
-
Ciprofloxacin (Cipro)
-
Norfloxacin
-
Anti-Bacterial Agents (Antibiotics)
-
Amoxicillin (Wymox)
Show All >>
Therapies Related to Trimethoprim-Sulfamethoxazole Combination
-
Aftercare (After-Treatment)
-
Transplants (Transplant)
-
Drug Therapy (Chemotherapy)
-
Transplantation (Transplant Recipients)
-
Chemoprevention
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.